訊聯基因 4160.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 4160)
4160 Value Score
3
24
15
Excellent Growth
- AI analysis rates 4160 with the highest value score of 5.
- It is mainly due to stable revenue growth, along with stable operating cash flow.
- Over the past 3 months, 4160 has maintained a consecutive value rating of 5.0, slightly higher than the rating of 4.5 over the past 3 years, indicating continued upward trend in enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 4160 has a higher value rating.
4160 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/21 (Weekly Update)
4160 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
4160 Earnings Table
No related data records
4160 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
4160 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 4160 from 2012/09 till Now
- 210.73%
- Cumulative Return
- 9.70%
- Annual Return
- 32.87%
- Volatility
- 0.29
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from September, 2012 to May, 2025. (Total Trades: 2)
| 4160 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 46% | 53% |
| Avg Return | 81.2% | 21.1% | 45.4% |
| Avg Profit | 81.2% | 72.2% | 102.9% |
| Avg Loss | - | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)